Danaparoid and haemoglobin decreased Patient Reports February 12, 2012

Danaparoid Side Effects Report #5984587-3
Danaparoid side effect was reported by a Consumer or non-health professional from AUSTRIA on Nov 19, 2008. Female patient, 46 years of age, was diagnosed with thrombosis and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, disease recurrence, embolism venous, haemoglobin decreased, paresis, vaginal haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, ALPROSTADIL, ANALGESICS. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5086058-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 11, 2006. Female patient, 93 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, disseminated intravascular coagulation, haemoglobin decreased, haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with PIPERACILLIN, AZTREONAM, ANTITHROMBIN III. Patient died.

Danaparoid Side Effects Report #5124739-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 21, 2006. Female patient, 93 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: concomitant disease aggravated, haemoglobin decreased, haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with PIPERACILLIN, AZTREONAM, ANTITHROMBIN III. Patient died.

Danaparoid Side Effects Report #4968053-X
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Dec 27, 2005. Female patient, 92 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, gastrointestinal haemorrhage, haemoglobin decreased. Danaparoid dosage: unknown. During the same period patient was treated with CIPROFLOXACIN HYDROCHLORIDE, PRODIF, PLATELETS, PLASMA PROTEIN FRACTION, RED BLOOD CELLS, PLASMA PROTEIN FRACTION. Patient died.


Danaparoid Side Effects Report #4977383-7
Danaparoid side effect was reported by a Physician from JAPAN on Apr 03, 2006. Female patient, 92 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, haemoglobin decreased, laboratory test abnormal. Danaparoid dosage: unknown. During the same period patient was treated with CIPROFLOXACIN HYDROCHLORIDE, PRODIF, PLATELETS, PLASMA PROTEIN FRACTION, RED BLOOD CELLS, PLASMA PROTEIN FRACTION. Patient died.

Danaparoid Side Effects Report #5026915-1
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 05, 2006. Female patient, 92 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood urea increased, disseminated intravascular coagulation, gastrointestinal haemorrhage, haemoglobin decreased. Danaparoid dosage: unknown. During the same period patient was treated with CIPROFLOXACIN HYDROCHLORIDE, PRODIF, PLATELETS, PLASMA PROTEIN FRACTION, RED BLOOD CELLS, PLASMA PROTEIN FRACTION. Patient died.

Danaparoid Side Effects Report #5150852-5
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Oct 30, 2006. Male patient, 90 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, gastric haemorrhage, haemoglobin decreased, red blood cell count decreased, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, MICAFUNGIN, ANTITHROMBIN III, VANCOMYCIN. Patient recovered.

Danaparoid Side Effects Report #4976158-2
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Dec 27, 2005. Male patient, 86 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: haemoglobin decreased, infection . Danaparoid dosage: unknown. During the same period patient was treated with IMMUNOGLOBULINS, GABEXATE MESILATE, CARBENIN, ULINASTATIN, PLASMA PROTEIN FRACTION. Patient died.

Danaparoid Side Effects Report #5077936-4
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 02, 2006. Male patient, 82 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, condition aggravated, haemoglobin decreased, platelet count increased, upper gastrointestinal haemorrhage, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with MICAFUNGIN, METHYLPREDNISOLONE SUCCINATE, PLATELETS, PLASMA PROTEIN FRACTION, CARBENIN. Patient died.


Danaparoid Side Effects Report #5118898-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 19, 2006. Female patient, 82 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood urea increased, condition aggravated, haemoglobin decreased, pneumonia , upper gastrointestinal haemorrhage, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with DORIPENEM HYDRATE, ROXATIDINE ACETATE. Patient died.

Danaparoid Side Effects Report #4975616-4
Danaparoid side effect was reported by a Health Professional from JAPAN on Dec 27, 2005. Male patient, 82 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, haemoglobin decreased, infection , upper gastrointestinal haemorrhage, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with MICAFUNGIN, METHYLPREDNISOLONE SUCCINATE, PLATELETS, PLASMA PROTEIN FRACTION, CARBENIN. Patient died on 01/21/2005.

Danaparoid Side Effects Report #4976159-4
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Dec 27, 2005. Male patient, 82 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neoplasm malignant, upper gastrointestinal haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with AMINOLEBAN, OMEPRAZOLE, GABEXATE MESILATE, ULINASTATIN, IMMUNE GLOBULIN INTRAVENOUS, BICARBONATE, FUROSEMIDE. Patient died.

Danaparoid Side Effects Report #5006923-7
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on May 09, 2006. Female patient, 82 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: haemoglobin decreased, pneumonia , upper gastrointestinal haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with DORIPENEM HYDRATE, ROXATIDINE ACETATE. Patient died.

Danaparoid Side Effects Report #5027820-7
Danaparoid side effect was reported by a Health Professional from JAPAN on June 05, 2006. Male patient, 82 years of age, was diagnosed with disseminated intravascular coagulation, pulmonary mycosis, shock, pneumonia  and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, haemoglobin decreased, upper gastrointestinal haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with MICAFUNGIN, METHYLPREDNISOLONE SUCCINATE, PLATELETS, PLASMA PROTEIN FRACTION, CARBENIN. Patient died.


Danaparoid Side Effects Report #5027821-9
Danaparoid side effect was reported by a Health Professional from JAPAN on June 05, 2006. Male patient, 82 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: haemoglobin decreased, upper gastrointestinal haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with AMINOLEBAN, OMEPRAZOLE, GABEXATE MESILATE, ULINASTATIN, IMMUNE GLOBULIN INTRAVENOUS, BICARBONATE, FUROSEMIDE. Patient died.

Danaparoid Side Effects Report #5046810-1
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 23, 2006. Female patient, 82 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, haemoglobin decreased, hepatic function abnormal, pneumonia , renal impairment, upper gastrointestinal haemorrhage, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with DORIPENEM HYDRATE, ROXATIDINE ACETATE. Patient died.

Danaparoid Side Effects Report #5031769-3
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Oct 13, 2005. Male patient, 80 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: haemoglobin decreased, haemorrhage, infection . Danaparoid dosage: unknown. During the same period patient was treated with CEFEPIME HYDROCHLORIDE, MEROPENEM, AMINO ACIDS NOS W, SIVELESTAT, OMEPRAZOLE. Patient died.

Danaparoid Side Effects Report #5108484-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 18, 2006. Female patient, 78 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, condition aggravated, gastrointestinal haemorrhage, haematocrit decreased, haemoglobin decreased, multi-organ failure, red blood cell count decreased, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with MEROPENEM TRIHYDRATE, FAMOTIDINE, CLINDAMYCIN PHOSPHATE, PAZUFLOXACIN, HYDROCORTISONE SUCCINATE, MICAFUNGIN, GABEXATE MESILATE, CARPERITIDE. Patient was hospitalized. Patient died.

Danaparoid Side Effects Report #5062421-6
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on July 20, 2006. Male patient, 77 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: fibrin d dimer increased, haematocrit decreased, haemoglobin decreased, haemorrhage, renal failure, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, ANTITHROMBIN III, BROMHEXINE HYDROCHLORIDE, DOPAMINE, DOBUTAMINE, NORADRENALINE, ALBUMIN, PRIMAXIN. Patient recovered.


Danaparoid Side Effects Report #4967758-4
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Mar 26, 2006. Female patient, 76 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood creatinine increased, blood potassium increased, blood urea increased, cardiac disorder, condition aggravated, haematocrit decreased, haemoglobin decreased, haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with PANCURONIUM BROMIDE, GABEXATE MESILATE, CEFOZOPRAN HYDROCHLORIDE, THEOPHYLLINE, PROPOFOL. Patient died.

Danaparoid Side Effects Report #4975619-X
Danaparoid side effect was reported by a Health Professional from JAPAN on Mar 23, 2006. Female patient, 76 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: asthma , blood bilirubin increased, blood potassium increased, disseminated intravascular coagulation, emphysema, haematocrit decreased, haemoglobin decreased, multi-organ failure, red blood cell count decreased. Danaparoid dosage: unknown. During the same period patient was treated with PANCURONIUM BROMIDE, GABEXATE MESILATE, CEFOZOPRAN HYDROCHLORIDE, THEOPHYLLINE, PROPOFOL. Patient died on 09/29/2003.

Danaparoid Side Effects Report #5027829-3
Danaparoid side effect was reported by a Health Professional from JAPAN on June 01, 2006. Female patient, 76 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood creatinine increased, blood potassium increased, blood urea increased, cardiac disorder, condition aggravated, haematocrit decreased, haemoglobin decreased, haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with PANCURONIUM BROMIDE, GABEXATE MESILATE, CEFOZOPRAN HYDROCHLORIDE, THEOPHYLLINE, PROPOFOL. Patient died.

Danaparoid Side Effects Report #4873368-X
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Dec 21, 2005. Male patient, 75 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood pressure decreased, gastrointestinal haemorrhage, haemoglobin decreased, haemoptysis. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, RIFAMPICIN, ISONIAZID, PYRIDOXAL PHOSPHATE. Patient died.

Danaparoid Side Effects Report #4948454-6
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Mar 08, 2006. Male patient, 75 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, blood bilirubin increased, blood creatine increased, blood potassium increased, blood pressure decreased, gastrointestinal haemorrhage, haemoglobin decreased, haemoptysis, white blood cell count decreased. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, RIPAMPICIN, ISONIAZID, PYRIDOXAL PHOSPHATE. Patient died.


Danaparoid Side Effects Report #5051299-2
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 22, 2006. Male patient, 70 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, gallbladder disorder, haemoglobin decreased, haemorrhagic diathesis, hepatic ischaemia, liver disorder. Danaparoid dosage: unknown. During the same period patient was treated with CEFEPIROME SULPHATE, ISEPAMICIN SULPHATE, MINOPHAGEN C, GLUTATHIONE, MIDAZOLAM HYDROCHLORIDE, VECURONIUM BROMIDE, DOPAMINE, VERAPAMIL HYDROCHLORIDE. Patient recovered.

Danaparoid Side Effects Report #5051297-9
Danaparoid side effect was reported by a Health Professional from JAPAN on July 04, 2006. Male patient, 69 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, haemoglobin decreased, haemorrhage, haemorrhagic diathesis, henoch-schonlein purpura, renal disorder, staphylococcal infection . Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN, DEXPANTHENOL, ALPROSTADIL, MEROPENEM, MINOPHAGEN C, VANCOMYCIN, WARFARIN. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5031771-1
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Oct 11, 2005. Female patient, 69 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: haemoglobin decreased, haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with NAFAMOSTAT MESILATE, ACLARUBICIN HYDROCHLORIDE, CYTARABINE, GRANISETRON, GABEXATE MESILATE, CEFEPIME HYDROCHLORIDE, AMIKACIN SULPHATE, CARBENIN. Patient died.

Danaparoid Side Effects Report #4985074-1
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 25, 2005. Female patient, 66 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, cardiac tamponade, gamma-glutamyltransferase increased, haematocrit decreased, haemoglobin decreased, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with GLYCEOL, CEFPIROME SULPHATE, EDARAVONE. Patient died.

Danaparoid Side Effects Report #5020447-2
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on May 24, 2006. Male patient, 66 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, cerebral haemorrhage, haemoglobin decreased, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with DOPAMINE HDYROCHLORIDE, CEFTAZIDIME, AMIKACIN SULPHATE, FLUBIPROFEN AXETIL, GLYCEROL, CARBAZOCHROME, TRANEXAMIC ACID. Patient died.


Danaparoid Side Effects Report #5056233-7
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 06, 2006. Male patient, 61 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, haemoglobin decreased, haemorrhage, neoplasm malignant. Danaparoid dosage: unknown. During the same period patient was treated with ULINASTATIN, SIVELESTAT, ANTITHROMBIN III, IMMUNE GLOBULIN INTRAVENOUS, FLOMEX, FAMOTIDINE, PROPOFOL. Patient died.

Danaparoid Side Effects Report #5153401-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Oct 30, 2006. Male patient, 57 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, haemoglobin decreased, haemorrhage, hepatic function abnormal, multi-organ failure, neoplasm malignant, renal impairment. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, NAFAMOSTAT MESILATE, DOPAMINE, OMEPRAZOLE, CEFOZOPRAN HYDROCHLORIDE, ANTITHROMBIN III, ULINASTATIN. Patient died.

Danaparoid Side Effects Report #5063640-5
Danaparoid side effect was reported by a Physician from JAPAN on July 06, 2006. Male patient, 56 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood creatinine increased, blood urea increased, condition aggravated, haemoglobin decreased, upper gastrointestinal haemorrhage, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with NAFAMOSTAT MESILATE, ANTITHROMBIN III, FAMOTIDINE. Patient died.

Danaparoid Side Effects Report #4974425-X
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Jan 05, 2004. Male patient, 56 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, haemoglobin decreased, pre-existing disease. Danaparoid dosage: unknown. During the same period patient was treated with NAFAMOSTAT MESILATE, ANTITHROMBIN III, FAMOTIDINE. Patient died.

Danaparoid Side Effects Report #5020454-X
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Apr 04, 2006. Female patient, 56 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood bilirubin increased, condition aggravated, gastric ulcer haemorrhage, haematocrit decreased, haemoglobin decreased, platelet count decreased, protein total decreased, sepsis , white blood cell count decreased. Danaparoid dosage: unknown. During the same period patient was treated with SULPERAZON, FAMOTIDINE, CARBAZOCHROME SULFONATE, TRANEXAMIC ACID, FLURBIPROFEN, NEUPOGEN, METHYLPREDNISOLONE SUCCINATE, ISEPAMICIN SULPHATE. Patient died.


Danaparoid Side Effects Report #4707197-4
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on June 23, 2005. Female patient, 78 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: dialysis , haematoma, haemoglobin decreased, lung disorder, pseudomonas infection, renal failure, shock. Danaparoid dosage: unknown. During the same period patient was treated with CEFEPIME HYDROCHLORIDE, AMIKACIN, NEFOPAM HYDROCHLORIDE, TRIMEBUTINE, METOCLOPRAMIDE, ACETAMINOPHEN, OMEPRAZOLE. Patient recovered.